Home
Conditions
Graft vs Host Disease

Clinical trial condition

Graft vs Host Disease

Explore clinical trials studying Graft vs Host Disease. Study availability and eligibility vary by location and protocol.

467 public trials 74 recruiting studies

Refine in advanced search Browse all conditions

Graft vs Host Disease trial results

Completed

Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD

NCT02824653

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations: Armed Forces Bone Marrow Transplant Centre Rawalpindi, Punjab Province, Pakistan

View Trial Details

Completed

Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease

NCT00053976

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Immune System Diseases
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

University of Minnesota Cancer Center Minneapolis, Minnesota, United States

View Trial Details

Completed

Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy.

NCT01174277

Conditions: Blood Stem Cell Transplant Failure, Bronchial Diseases, Bronchiolitis, +10 more
Locations: University of Kansas Medical Center Kansas City, Kansas, United States

Children's Mercy Hospital Kansas City, Missouri, United States

View Trial Details

Completed

Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease

NCT01174940

Conditions: Bone Marrow Diseases, Graft Versus Host Disease, Graft vs Host Disease, +17 more
Locations: University of Kansas Medical Center Kansas City, Kansas, United States

View Trial Details

Completed

Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation

NCT00429416

Conditions: Graft vs Host Disease, Hematologic Diseases, Hematologic Malignancies, +5 more
Locations: Thomas Jefferson University' Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.

NCT01222039

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +10 more
Locations: Hospital de Jerez de la Frontera. Jerez de la Frontera, Cádiz., Spain

Hospital Universitario Virgen de las Nieves Granada, Granada., Spain

Hospital Universitario Virgen del Rocío de Sevilla Seville, Sevilla, Spain

Hospital Clínico de Valencia Valencia, Spain

View Trial Details

Completed

Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS

NCT00025662

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +31 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation

NCT01206309

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +7 more
Locations: Mayo Clinic Scottsdale, Arizona, United States

Stanford University Stanford, California, United States

H. Lee Moffitt Cancer Center Tampa, Florida, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View all 14 locations

View Trial Details

Completed

Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide

NCT00800839

Conditions: Graft vs Host Disease, Hematologic Diseases, Hematologic Neoplasms, +12 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus

NCT00133367

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Graft vs Host Disease, +27 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Graft vs Host Disease

Graft vs Host Disease trial results

Related conditions